Loading clinical trials...
Loading clinical trials...
Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients With AL (Primary)Amyloidosis. A Prospective Randomized Trial .
Conditions
Interventions
Melphalan
Dexamethasone
+1 more
Locations
8
France
Service des Maladies du Sang
Lille, France
Service d'Hématologie et de Thérapie cellulaire
Limoges, France
Service d'hématologie clinique
Nantes, France
Service d'hématologie Clinique, Groupe Hospitalier Pitié-Salpétrière
Paris, France
Service d'hématologie clinique, Hôpital Necker
Paris, France
Service d'immuno-hématologie, Hôpital Saint-Louis
Paris, France
Start Date
January 1, 2000
Completion Date
June 1, 2006
Last Updated
June 28, 2007
Lead Sponsor
University Hospital, Limoges
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions